Canos
YC F26Oxford, GB · Founded 2026 · 1 known investors
Find your way into Canos
Sign up to see every warm intro you have to Canos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Canos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Canos offers a liquid biopsy service for pets that sequences cell-free DNA from a single blood draw to detect cancer signals through fragmentation, copy number variation, and methylation analysis, enabling annual baseline tracking and monitoring of diagnosed animals. Working with mobile vets and clinics in San Francisco and New York, it serves dog owners, with plans to extend to cats.
Founders & leadership· Y Combinator alumni (F26)
MT

Ming-shan TsaiFounder/CEOFounder and CEO of Canos. Previously co-founded ZYTCA and served as its CSO, where he launched veterinary diagnostic products including an AI-driven digital pathology system distributed to vet clinics in China. He holds a biology PhD from Oxford and has a background spanning business management and human and animal health.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- CANOS LTD
- Company number
- 17153169
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 13 Apr 2026
- Registered office
- 61 Lime Walk, Headington, Oxford, OX3 7AB
- Nature of business (SIC)
- 32500 — Manufacture of medical and dental instruments and supplies71200 — Technical testing and analysis72110 — Research and experimental development on biotechnology74909 — Other professional, scientific and technical activities n.e.c.
- Previous names
- EPICLUE LTD (2026–2026)CANOS LIMITED (2026–2026)
- Accounts
- next due 13 Jan 2028
- Confirmation statement
- next due 26 Apr 2027
Current officers · 1
- Ming-Shan Tsai — director, appointed 13 Apr 2026
Source: Companies House public register · retrieved 1 Nov 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Canos do?
- Canos offers a liquid biopsy service for pets that sequences cell-free DNA from a single blood draw to detect cancer signals through fragmentation, copy number variation, and methylation analysis, enabling annual baseline tracking and monitoring of diagnosed animals. Working with mobile vets and clinics in San Francisco and New York, it serves dog owners, with plans to extend to cats.
- Who are Canos's investors?
- Canos's investors include Y Combinator.
- Where is Canos headquartered?
- Canos is headquartered in Oxford, GB.

